Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum Effective Dose of Ropivacaine for Adductor Canal Block in TKA
NCT03427385Completed
- Sponsor
- University Health Network
- Start
- Sep 2012
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Single-arm trial of ropivacaine in postoperative pain, sponsored by University Health Network. Primary endpoint: Tolerance to Transcutaneous Electrical Stimulation. Started Sep 2012; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03427385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03427385.